Trial intelligence / Profile preview

Palonosetron vs Granisetron for CINV in Asian Population

NCT00503386Phase 2Completed

Sponsor
Jiuyuan Gene Engineering
Start
Apr 2006
Primary completion
Oct 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Jiuyuan Gene Engineering. Started Apr 2006; status: completed.

02

Drugs

palonosetron
03

Conditions

chemotherapy-induced nausea and vomiting (CINV)

Beyond the preview

Go deeper on NCT00503386.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00503386.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call